ProcureCon Pharma (past event)
28 February - 02 March, 2017
44 (0) 207 368 9459
Day 1 – February 28, 2017
08:00 - 08:45 Welcome and Registration
Collect your badge, grab a coffee and start networking
08:45 - 08:50 Organiser’s Welcome - Tom Webber, Director, ProcureCon Pharma
08:50 - 09:00 Chairperson’s Address
Find out how the Pharma sector is evolving including the main challenges ahead and how procurement fits into the bigger picture from a senior industry expert.
09:00 - 09:40 CPO Interactive Case Study – Bringing the Outside In: GSK Global Procurement Approach to Risk and Innovation
Find out how GSK global procurement is working with the business to develop a culture to recognise and manage risk and innovation. Addressing how innovation is being done at product and process levels as well as with partners and how risk is being managed in business environments including China, this interactive session offers new insights from a truly thought-provoking business leader.
- How cultural change in GSK procurement is driving new priorities around innovation
- How GSK procurement is stepping up the link between suppliers and innovation
- Lessons learned and recent experiences managing risk in China
- Emerging challenges around sourcing innovation and managing risk with start-ups
09:40 - 10:00 How to Enable Innovation and Eliminate Risk by Continuously Improving Supplier Performance
Session information to come
10:00 - 10:45 Panel Discussion – Exploring Procurements’ Expanding Role in Enabling Supplier Innovation
As Pharma businesses increasingly turn to Innovation as the competitive differentiator in both existing and new markets find out how senior business leaders believe procurement will play a new and exciting role during this interactive discussion. With representatives from big, medium and smaller Pharma businesses, this panel offers you a comprehensive view on a critical topic.
- Exploring how and why ‘Innovation’ is experiencing a renaissance in Pharma as a business-wide priority
- What is the business case and what are the metrics to use when targeting ‘more innovation’ through procurement?
- Examples from different Pharma businesses as they address Innovation through procurement
- When will ‘Innovation’ not ‘Savings’ be the driver for better procurement?
10:45 - 11:25 Break
Grab a coffee and start networking
11:25 - 11:55 VP Interview – Key Lessons Learned from the Development of Trusting, Profitable Relationships with Suppliers
Discover how experienced procurement leaders approach building more profitable supplier relationships from the newly appointed VP for Global Sourcing at Lonza, a medium size Pharma business. In this frank interview Volker will share recent examples of best practice engagement and collaboration with a range of Pharma suppliers from around the world to help you identify different strategies and methods of enabling innovation exchange and managing risk.
The Chartered Institute of Procurement and Supply (CIPS)
- How to de-complex relationships with suppliers to make your business more agile
- How to engage new suppliers in building more trusting, longer lasting relationships
- How to move your supplier relationships to new levels of innovation exchange
- Metrics to use to boost supplier performance and drive profitability of relationships
Will Beattie
General Manager, Continental EuropeThe Chartered Institute of Procurement and Supply (CIPS)
11:55 - 12:15 Simplifying and Improving Access to Human Biosamples and Other High Risk Scientific Services and Products
Find out how the Scientist.com marketplace simplifies access to hundreds of human biosamples and thousands of other custom research services during this session with the COO. Discover how the marketplace can be used to save time, reduce costs and access innovation as well as to ensure compliance with internal and external regulatory policies.
- Learn how to use a standard process to qualify human biosample providers
- Find and communicate with hundreds of human biosample providers
- Ensure user and supplier compliance with regulations governing human biosample acquisition
- Automatically append appropriate legal riders based on the sourcing category
12:15 - 12:55 Guest Opening Presentation: How to Build Stronger Relationships under Pressure
Find out how to build and manage teams in intense, pressurised situations and come through it all with better-than-hoped-for results. Drawing on a wealth of success in the F1 industry Nick Fry will share unique experiences working with some of the world’s most demanding racing drivers, quality obsessed engineers and unforgiving customers as he sets out his vision for better business partnering. Not to be missed this is a real highlight of the event.
.
- How to build a high performing team from scratch
- How to perform against the odds during periods of intense activity
- How to keep your team engaged and focused on your core goals
- Key steps to transforming an existing team into a world-class organisation
Cathy O’Dowd
1st woman to climb Everest from both sides.
Lunch
12:55 - 14:00 Lunch
Enjoy a 3-course meal whilst continuing your networking.
'Ask the Agency’ Lunch
12:55 - 14:00 'Ask the Agency’ Lunch
Find answers to questions you have around improving creativity, advertising & promotion, multichannel, medical communications, market access, business & brand consultancy and public health during this special lunch led by a panel of experts from McCann Health. Designed specificially for those responsible for Pharma marketing spend management, register early for one of the limited places and you can submit specific questions for the panel to address on the day.
Track A – Driving Innovation
14:00 - 14:40 Interactive Case Study - Rethinking the Role of Procurement in Driving the Innovation Agenda
So much innovation is happening that procurement often gets confused about its role. It may be wrong to act in isolation, building trust with R&D is a critical first step but this is easier said than done. Explore different roles for procurement in enabling Innovation with J&J’s leading expert on Innovation as Karina reveals the success factors required to find the right approach.
Johnson & Johnson
- What does Innovation mean to J&J?
- How J&J puts emphasis on supplier enabled innovation
- How to engage your R&D partners in designing and engineering Innovation
- Knowing what good looks like to start achieving excellence in Innovation
Karina Larson O'Halloran
Executive Director, Head of Global Innovation SourcingJohnson & Johnson
Track B - Accountability and Risk
14:00 - 14:40 Interactive Case Study – Lessons Learned from a Mid-Size Pharma Managing Global Supplier RiskTrack A – Driving Innovation
14:40 - 15:20 Interactive Case Study - Innovative Ways to Engage Suppliers in a ‘Should-Cost’ Approach to Co-Deliver Savings to Your Business
Find out how to bring about synergies from cross functional teams that collaborate well. Using a recent project as an example of cross functional teamwork between Sourcing, R&D and the CRO, Patrik will outline why internal technical capability in the area is vital. He will also explain why it is so important to demonstrate the validity of the model as executed with CROs and CMOs.
- How stability studies are carried out to assess the variation in quality over time of a drug substance and finished product under the influence of numerous environmental conditions
- Introducing a ‘should-cost’ model to calculate the cost of performing analytical tests and captures cost efficiency when pooling coherent pull points in any given stability study
- How a collaborative approach by sourcing managers, scientists and CROs can lead to studies that ensure steps towards analysis coincide
- How to engage CMOs/CROs in multi-area analysis thus creating a powerful negotiation
Track B - Accountability and Risk
14:40 - 15:20 Interactive Case Study - How MERCK Envisioned and Developed a Sound Supplier Risk Management Concept. A story of Faith, Growth… and Success?
Find out how Eduard draws on his 20 years’ experience in sourcing to lead a relatively new Centre of Excellence for Risk Management at Merck. Learn about the organisation of the CoE, its goals and current status of projects it is overseeing. Discover how recent pilot programmes to implement risk management tools is progressing and lessons learned along the way that could save you time and challenge your thinking too.
- How Merck’s procurement organisation in Europe is being restructured to enable more agility
- How Risk Management fits into the overall structure of the new Centres of Excellence for Supplier Management, Insights and Analytics and Sustainability
- How risk assessment initiatives have led to more far-reaching risk management techniques across the procurement organisation
- How risk will be anticipated, prepared for, reported and managed in the future
Track C - Synergy Workshops
14:40 - 15:20 How to Gain Privileged Access to Supplier Innovation
Join 20 of your peers for this highly interactive workshop so you can gain more privileged access to supplier innovation and improve your business’ competitiveness as a result. Drawing on 20 years’ experience Thierry will mix proven methods to win more innovation from suppliers with real-life scenarios in which you can test your own approach against different industry benchmarks.
- Knowing your supplier ecosystem
- What motivates suppliers to share innovation?
- Understanding the levers for innovation
- Tackling the idea that innovation comes at a premium
Track A – Driving Innovation
15:20 - 16:00 Panel Discussion – Rethinking How to Work with Suppliers to Drive Clinical Innovation
Speakers:
Patrik Rojecki Senior Sourcing Manager Global Pharma R&D Ferring Pharmaceuticals
Cristian Lienas Sales & Marketing Strategic Sourcing Manager, Global Sourcing Almirall
Paula Davila Martinez Vice President & Chief Procurement Officer UCB Biopharma
Moderator:
James Heidrich Global Procurement Productivity Leader Smith and Nephew
Patrik Rojecki Senior Sourcing Manager Global Pharma R&D Ferring Pharmaceuticals
Cristian Lienas Sales & Marketing Strategic Sourcing Manager, Global Sourcing Almirall
Paula Davila Martinez Vice President & Chief Procurement Officer UCB Biopharma
Moderator:
James Heidrich Global Procurement Productivity Leader Smith and Nephew
Track B - Accountability and Risk
15:20 - 16:00 Panel Discussion – Best Practice Risk Management
Speakers:
Eduard Bagan Head, Centre of Excellence, Risk Management Merck
Gareth Crowder Senior Category Manager Norgine
Richard Pompe Director, Global Sourcing & Partnerships Ipsen Bioinnovation
Moderator:
Daniel Christen Group Leader Planning & Procurement Technical Operations Actelion Pharmaceuticals
Eduard Bagan Head, Centre of Excellence, Risk Management Merck
Gareth Crowder Senior Category Manager Norgine
Richard Pompe Director, Global Sourcing & Partnerships Ipsen Bioinnovation
Moderator:
Daniel Christen Group Leader Planning & Procurement Technical Operations Actelion Pharmaceuticals
Richard Pompe
Director, Global Sourcing & PartnershipsIpsen Bioinnovation
Daniel Christen
Group Leader Planning & Procurement Technical OperationsActelion Pharmaceuticals
Track C - Synergy Workshops
15:20 - 16:00 Session Continued16:00 - 16:40 Break
Grab a coffee and continue networking.
Track A - Best Practice Supplier Partnering
16:40 - 17:20 Interactive Case Study: Putting Power Into Supplier Partnerships: Potential x People x Process x PreparationSteve Cray
Director Supplier Relationship Management, Small Molecule Operating UnitShire Pharmaceuticals
Track B – Practical ‘How to’ Roundtable Discussions
16:40 - 17:20 Roundtables
Speakers:
Julie Adrian European Managing Director inVentiv Health Communications
Cristina Martí Managing Director Indukern Chemie AG
Irina Ringler Senior Director, Site Intelligence, Site Centricity Unit inVentiv Health
Arno Bock Vice-President, Commercial Business Development inVentiv Health
Darren Lynch Vice President, Consulting GEP
Julie Adrian European Managing Director inVentiv Health Communications
Cristina Martí Managing Director Indukern Chemie AG
Irina Ringler Senior Director, Site Intelligence, Site Centricity Unit inVentiv Health
Arno Bock Vice-President, Commercial Business Development inVentiv Health
Darren Lynch Vice President, Consulting GEP
1 Unlocking Full Commercial Potential by Better Integrating Clinical Development and Commercial Planning
Attendees will participate in an interactive discussion aimed at key opportunities for patient engagement in clinical and commercial strategies. Participants will discuss how the patient’s voice can be leveraged earlier in the drug development process and how this drives better health and commercial outcomes.
Irina Ringler Senior Director, Site Intelligence, Site Centricity Unit, inVentiv Health Clinical
Arno Bock, Vice President, Commercial Business Development, inVentiv Health
2 How to Engage Your Supplier Ecosystem in Anticipating and Managing Risks as You See Them
Darren Lynch, Vice President Consulting Europe, GEP
3 Partnering as a New Procurement Approach for the API Market: Broadening Market Intelligence, Improving Security of Supply and Co-Managing Risk
Dr Cristina Marti, Managing Director, Indukern Chemie AG
Attendees will participate in an interactive discussion aimed at key opportunities for patient engagement in clinical and commercial strategies. Participants will discuss how the patient’s voice can be leveraged earlier in the drug development process and how this drives better health and commercial outcomes.
Irina Ringler Senior Director, Site Intelligence, Site Centricity Unit, inVentiv Health Clinical
Arno Bock, Vice President, Commercial Business Development, inVentiv Health
2 How to Engage Your Supplier Ecosystem in Anticipating and Managing Risks as You See Them
Darren Lynch, Vice President Consulting Europe, GEP
3 Partnering as a New Procurement Approach for the API Market: Broadening Market Intelligence, Improving Security of Supply and Co-Managing Risk
Dr Cristina Marti, Managing Director, Indukern Chemie AG
Track A - Best Practice Supplier Partnering
17:20 - 18:00 Interactive Case Study – How Sanofi Procurement Europe is Rethinking Relationships to Become More Agile and Adaptive to Change
Find out how Sanofi’s new head of procurement in Europe will interpret the business’ goals into procurement strategy whilst successfully managing relationships inside and outside the business. With a new operating environment inside the group, a vision for a new vendor landscape to realise and increasing pressure to deliver on innovation whilst managing risk, Arnaud has an interesting set of challenges to tell you about in 2017.
Sanofi
- Sanofi Europe’s role in the global procurement strategy
- Progress in the implementation of a new vertical procurement organisation at Sanofi
- How procurement is continuously realigning its strategy with changing business goals
- Incremental versus disruptive innovation – how Sanofi procurement will enable co-development of innovation with new types of suppliers
Benoit Ferauge
Deputy of the Domain Head of Category Managers Common Spend and Marketing SSanofi
Track B – Practical ‘How to’ Roundtable Discussions
17:20 - 18:00 Session Continued18:00 - 18:05 Chairperson’s Summary and Roundtable Reports
Receive an overview and quick take-aways from today’s sessions to share with your colleagues back in the office